This competing renewal application seeks to extend a paradigm that places? the epidermal keratinocyte in a central role Th the recruitment and? maintenance of T cell infiltration into skin. During the first funding? cycle. the principal investigator identified a series of novel cytokines? produced by keratinocytes and attempted to integrate them into coherent? models of cutaneous inflammation. Such models have been fundamentally? intestable in vivo, however, until very recently. In this application, an? approach will be used involving transgenic mice constructed so as to? express different cytokines and adhesion molecules in epidermis. In this? fashion, hypotheses that epidermal cytokines and adhesion molecules are? involved in certain types of inflammation can be tested experimentally with? scientific rigor.? The present proposal will focus on interactions between T cells and? keratinocytes, and has evolved to incorporate not only cytokines produced? by keratinocytes that influence T cells, but also keratinocyte adhesion? molecules that bind to T cell surface molecules and can costimulate T? cells. Using a keratin 14 (basal keratinocyte) promoter, we have made? transgenic mice that constitutively express ICAM-1, B7, and lL-7 in? epidermis; the first two molecules are important in T cell costimulation,? and the third is a potent T cell growth factor. Each of these molecules has? been reported to be expressed under certain conditions by keratinocytes in? vitro and in vivo.? Three aims are proposed. In the first, the role of B7 and ICAM- 1? expression on keratinocytes in the capacity of keratinocytes to activate T? cells in vivo and in vitro will be studied. In the second, the ability of? constitutive epidermal production of IL- 7, coupled with secondary stimuli,? to recruit and sustain a T cell infiltrate will be studied. In the third,? the capacity of these transgenes expressed by experimentally induced? keratinocytederived neoplasms to elicit a T cell mediated anti-tumor? response will be evaluated. These questions, which can only be answered in? our transgenic system, will provide important insights into the? relationship between keratinocytes, T cells, and skin disease.?

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37AI025082-19
Application #
7174291
Study Section
Special Emphasis Panel (NSS)
Program Officer
Togias, Alkis
Project Start
1989-08-01
Project End
2009-01-31
Budget Start
2007-02-01
Budget End
2009-01-31
Support Year
19
Fiscal Year
2007
Total Cost
$358,697
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115
Jiang, Xiaodong; Clark, Rachael A; Liu, Luzheng et al. (2012) Skin infection generates non-migratory memory CD8+ T(RM) cells providing global skin immunity. Nature 483:227-31
Clark, Rachael A; Watanabe, Rei; Teague, Jessica E et al. (2012) Skin effector memory T cells do not recirculate and provide immune protection in alemtuzumab-treated CTCL patients. Sci Transl Med 4:117ra7
Liu, Luzheng; Zhong, Qiong; Tian, Tian et al. (2010) Epidermal injury and infection during poxvirus immunization is crucial for the generation of highly protective T cell-mediated immunity. Nat Med 16:224-7
Jiang, Xiaodong; Campbell, James J; Kupper, Thomas S (2010) Embryonic trafficking of gammadelta T cells to skin is dependent on E/P selectin ligands and CCR4. Proc Natl Acad Sci U S A 107:7443-8
Clark, Rachael A; Kupper, Thomas S (2006) Misbehaving macrophages in the pathogenesis of psoriasis. J Clin Invest 116:2084-7
Clark, Rachael A; Chong, Benjamin F; Mirchandani, Nina et al. (2006) A novel method for the isolation of skin resident T cells from normal and diseased human skin. J Invest Dermatol 126:1059-70
Clark, Rachael A; Chong, Benjamin; Mirchandani, Nina et al. (2006) The vast majority of CLA+ T cells are resident in normal skin. J Immunol 176:4431-9
Clark, Rachael A; Yamanaka, Kei-ichi; Bai, Mei et al. (2005) Human skin cells support thymus-independent T cell development. J Clin Invest 115:3239-49
Robert, C; Klein, C; Cheng, G et al. (2003) Gene therapy to target dendritic cells from blood to lymph nodes. Gene Ther 10:1479-86